Cargando…

Hepatic metastases in ovarian cancer

Detalles Bibliográficos
Autores principales:	Shan, Ying, Jin, Ying, Pan, Lingya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745623/ https://www.ncbi.nlm.nih.gov/pubmed/36523920 http://dx.doi.org/10.21037/hbsn-22-484

Ejemplares similares

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases
por: Ghirardi, Valentina, et al.
Publicado: (2023)

Pregnancy and oncologic outcomes of early stage low grade epithelial ovarian cancer after fertility sparing surgery: a retrospective study in one tertiary hospital of China
por: Yin, Jie, et al.
Publicado: (2019)

Rectosigmoid sparing en bloc pelvic resection for fixed ovarian tumors: Surgical technique and perioperative and oncologic outcomes
por: Shan, Ying, et al.
Publicado: (2022)

Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients
por: Yin, Jie, et al.
Publicado: (2012)

The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery
por: Zeng, Jing, et al.
Publicado: (2017)

Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer
por: Niu, Guang-cai, et al.
Publicado: (2012)

Systematic Lymph Node Dissection May Be Abolished in Patients With Apparent Early-Stage Low-Grade Mucinous and Endometrioid Epithelial Ovarian Cancer
por: Chen, Jiayu, et al.
Publicado: (2021)

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
por: Chen, Ming, et al.
Publicado: (2014)

Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma
por: Zeng, Jing, et al.
Publicado: (2016)

Metastases: the glycan connection
por: Couldrey, Christine, et al.
Publicado: (2000)

Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines
por: Chen, Ming, et al.
Publicado: (2015)

Multi-kinase inhibition in ovarian cancer
por: Dent, Paul
Publicado: (2014)

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
por: Chen, Jiayu, et al.
Publicado: (2021)

Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
por: Wang, Xueqing, et al.
Publicado: (2013)

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022)

Does the act of surgery provoke activation of "latent" metastases in early breast cancer?
por: Baum, Michael
Publicado: (2004)

Cutaneous Metastases in Ovarian Cancer
por: Otsuka, Isao
Publicado: (2019)

Treatment of ovarian cancer with modified anthrax toxin
por: Aktories, Klaus
Publicado: (2022)

Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data
por: Moschini, Marco, et al.
Publicado: (2018)

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
por: Sun, Hengzi, et al.
Publicado: (2018)

CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells
por: Yin, Jie, et al.
Publicado: (2022)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

Mutual cytokine crosstalk between colon cancer cells and microenvironment initiates development of distant metastases
por: Vaňhara, Petr, et al.
Publicado: (2013)

Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical Trial
por: Chen, Jiayu, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint blockade for brain metastases
por: Harary, Maya, et al.
Publicado: (2019)

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
por: Chiappinelli, Katherine B., et al.
Publicado: (2022)

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
por: Scully, Ralph
Publicado: (2000)

A Quest for Better Mouse Models of Breast and Ovarian Cancers
por: Harlan, Blaine A., et al.
Publicado: (2015)

Sarcoidosis manifesting as hepatic and splenic nodules mimicking ovarian cancer metastases: A case report
por: YONENAGA, YOSHIKUNI, et al.
Publicado: (2015)

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
por: Gemici, Cengiz, et al.
Publicado: (2015)

The Surgical Management of Proximal Femoral Metastases: A Narrative Review
por: Axelrod, Daniel, et al.
Publicado: (2021)

Commentary: A chance to cut is a chance to … prevent metastases?
por: Yeung, Jonathan C.
Publicado: (2020)

Ovarian transposition in rectal cancer: uncertain benefit at a high price
por: Fish, Rebecca
Publicado: (2022)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Emerging applications of tumour-educated platelets in the detection and prognostication of ovarian cancer
por: Zhu, Jiewei, et al.
Publicado: (2023)

Comment to “Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis”
por: Altundag, Kadri
Publicado: (2016)

How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
por: Minami, Yasunori, et al.
Publicado: (2022)

A case of early extraneural medulloblastoma metastases in a young adult
por: Amirjamshidi, Abbas
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r69ka9640gprvosm4jv0r6tvjl